{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T13:41:39Z","timestamp":1649684499895},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00108-022-01304-0","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T15:09:28Z","timestamp":1647616168000},"page":"180-185","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["80\/m mit schwer einstellbarer arterieller Hypertonie und Hypokali\u00e4mie"],"prefix":"10.1007","volume":"63","author":[{"given":"B.","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"1304_CR1","first-page":"202","volume-title":"Klinikleitfaden Nephrologie","author":"J Hoyer","year":"2021","unstructured":"Hoyer\u00a0J (2021) Elektrolythaushalt. In: Schwenger\u00a0V (Hrsg) Klinikleitfaden Nephrologie. Elsevier, , S\u00a0202\u2013224"},{"key":"1304_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1055\/a-1031-0612","volume":"145","author":"R D\u00fcsing","year":"2020","unstructured":"D\u00fcsing\u00a0R (2020) Therapieresistente und -refrakt\u00e4re Hypertonie. Dtsch Med Wochenschr 145:87\u201391","journal-title":"Dtsch Med Wochenschr"},{"issue":"40","key":"1304_CR3","first-page":"A-2548","volume":"93","author":"H Holzgreve","year":"1996","unstructured":"Holzgreve\u00a0H (1996) Die therapieresistente Hypertonie. Dtsch Arztebl 93(40):A-2548\u2013A-2552","journal-title":"Dtsch Arztebl"},{"key":"1304_CR4","unstructured":"Schmitz U (2012) Weiterf\u00fchrende Informationen und Differentialdiagnostik zur Zertifizierten Kasuistik \u201eSchwer einstellbare arterielle Hypertonie \u201c. https:\/\/www.aekno.de\/31-schwer-einstellbare-arterielle-hypertonie. Zugegriffen: 22.01.2022"},{"key":"1304_CR5","unstructured":"https:\/\/www.uptodate.com\/contents\/definition-risk-factors-and-evaluation-of-resistanthypertension. Zugegriffen: 22.01.2022"},{"key":"1304_CR6","first-page":"248","volume-title":"Klinikleitfaden Nephrologie","author":"M Hausberg","year":"2021","unstructured":"Hausberg\u00a0M, Kr\u00e4mer\u00a0B (2021) Arterielle Hypertonie. In: Schwenger\u00a0V (Hrsg) Klinikleitfaden Nephrologie. Elsevier, , S\u00a0248\u2013264"},{"issue":"2","key":"1304_CR7","first-page":"14","volume":"2","author":"A Tomaschitz","year":"2009","unstructured":"Tomaschitz\u00a0A, Dobnig\u00a0H (2009) Prim\u00e4rer Hyperaldosteronismus \u2013 die h\u00e4ufigste monokausale Ursache der \u201eessenziellen Hypertonie\u201c. J\u00a0Klin Endokrinol Stoffw 2(2):14\u201321","journal-title":"J Klin Endokrinol Stoffw"},{"issue":"10","key":"1304_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5414\/NHX02199","volume":"50","author":"F Srugies","year":"2021","unstructured":"Srugies\u00a0F, Stegbauer\u00a0J, Rump\u00a0LC (2021) Prim\u00e4rer Hyperaldosteronismus \u2013 Diagnostik und konservative Therapie in Winterberg B, Hahn KM (Gasteditoren). Prim\u00e4rer Hyperaldosteronismus. Nieren- Hochdruckkrankheiten 50(10):406\u2013416","journal-title":"Nieren- Hochdruckkrankheiten"},{"issue":"10","key":"1304_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.5414\/NHX02181","volume":"50","author":"S Gruber","year":"2021","unstructured":"Gruber\u00a0S, Beuschlein\u00a0F (2021) Prim\u00e4rer Hyperaldosteronismus und Hypokali\u00e4mie in Winterberg B, Hahn KM (Gasteditoren). Prim\u00e4rer Hyperaldosteronismus. Nieren- Hochdruckkrankheiten 50(10):435\u2013445","journal-title":"Nieren- Hochdruckkrankheiten"},{"issue":"10","key":"1304_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5414\/NHX02207","volume":"50","author":"KM Hahn","year":"2021","unstructured":"Hahn\u00a0KM, Winterberg\u00a0B (2021) Das Spektrum des prim\u00e4ren Hyperaldosteronismus \u2013 Implikationen f\u00fcr Pr\u00e4vention und Therapie in Winterberg\u00a0B, Hahn\u00a0KM (Gasteditoren). Prim\u00e4rer Hyperaldosteronismus. Nieren- Hochdruckkrankheiten 50(10):406\u2013416","journal-title":"Nieren- Hochdruckkrankheiten"},{"issue":"18","key":"1304_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3238\/arztebl.2009.0305","volume":"106","author":"C Schirpenbach","year":"2009","unstructured":"Schirpenbach\u00a0C, Segmiller\u00a0F, Diederich\u00a0S, Hahner\u00a0S, Lorenz\u00a0R, Rump\u00a0LC, Seufert\u00a0J, Quinkler\u00a0M, Bidlingmaier\u00a0M, Beuschlein\u00a0F, Endres\u00a0S, Reincke\u00a0M (2009) Diagnostik und Therapie des prim\u00e4ren Hyperaldosteronismus: Ergebnisse des deutschen Conn-Registers: 555 Patienten mit prim\u00e4rem Hyperaldosteronismus. Dtsch Arztebl Int 106(18):305\u2013311. https:\/\/doi.org\/10.3238\/arztebl.2009.0305","journal-title":"Dtsch Arztebl Int"},{"key":"1304_CR12","unstructured":"https:\/\/www.uptodate.com\/contents\/diagnosis-of-primary-aldosteronism. Zugegriffen: 22.01.2022"},{"key":"1304_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00108-021-00972-8","volume":"62","author":"UI Scholl","year":"2021","unstructured":"Scholl\u00a0UI (2021) Hyperaldosteronismus. Internist 62:245\u2013251","journal-title":"Internist"},{"key":"1304_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-2002-23491","volume":"110","author":"S Trenkel","year":"2002","unstructured":"Trenkel\u00a0S, Seifarth\u00a0C, Schobel\u00a0H, Hahn\u00a0EG, Hensen\u00a0J (2002) Ratio of serum aldosterone to plasma renin concentration in essential hyper-tension and primary aldosteronism. Exp Clin Endocrinol Diabetes 110:80\u201385. https:\/\/doi.org\/10.1055\/s-2002-23491","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"1304_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5414\/NHX02183","volume":"50","author":"GP Rossi","year":"2021","unstructured":"Rossi\u00a0GP, Rossitto\u00a0G, Seccia\u00a0TM (2021) Diagnostik des prim\u00e4ren Hyperaldosteronismus: Adrenales Venensampling in Winterberg B, Hahn KM (Gasteditoren). Prim\u00e4rer Hyperaldosteronismus. Nieren- Hochdruckkrankheiten 50(10):417\u2013426","journal-title":"Nieren- Hochdruckkrankheiten"},{"key":"1304_CR16","unstructured":"https:\/\/www.uptodate.com\/contents\/treatment-of-primary-aldosteronism. Zugegriffen: 22.01.2022"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01304-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01304-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01304-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T13:10:02Z","timestamp":1649682602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01304-0"}},"subtitle":["Vorbereitung auf die Facharztpr\u00fcfung: Fall 132"],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":16,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01304-0","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"10 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0Bader gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von der Autorin keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}